Tag Archive

SEC 第63页

Explore tools, prompts, skills, news and resources related to SEC 第63页.

On this page: 20 Prompts: 0 News: 0 Directory: 20

AI Tools & Directory

Discover tools, products and platforms related to SEC 第63页

ANMAT FNA

ANMAT FNA

ANMAT FNA

AI Chat
ENFree
ANMAT FNA provides free online access to Argentina's official pharmacopoeia for reference and regulatory information.

Korea Pharmacopoeia Online

Korea Pharmacopoeia Online

Korea Pharmacopoeia Online

AI Workflow
KOFree
A free Korean Ministry of Food and Drug Safety portal for searching official Korean pharmacopoeia and drug approval information.

Japanese Pharmacopoeia Online

Japanese Pharmacopoeia Online

Japanese Pharmacopoeia Online

AI Workflow
JAFree
The Japanese Pharmacopoeia Online provides free web access to Japan's official drug standards, including the latest JP18 edition, for pharmaceutical professionals and researchers.
USP-NF

USP-NF

AI Chat
ENFree · Paid
USP-NF Online is a web reference for accessing United States Pharmacopeia and National Formulary drug standards and monographs.
ChP

ChP

AI Chat
Zh-CNFree
ChP is a web-based reference for the 2020 Chinese Pharmacopoeia, offering online lookup of drug standards and monographs.

Argentine Pharmacopoeia

Argentine Pharmacopoeia

Argentine Pharmacopoeia

AI Chat
MoreFree
Official Argentine Pharmacopoeia for free online access and PDF download, serving as a reference for pharmaceutical standards.
Ph.Int

Ph.Int

AI Workflow
ENFree
Ph.Int is a free web-based reference for international pharmaceutical standards, useful for drug quality and regulatory research.
eCTD

eCTD

AI Workflow
Zh-CNFree
A web portal from China's CDE for electronic common technical document (eCTD) pharmaceutical submissions and related regulatory guidance.

CDE Consistency Evaluation

CDE Consistency Evaluation

CDE Consistency Evaluation

AI Workflow
Zh-CNFree
A Chinese regulatory portal for looking up consistency evaluation filings and supplementary submissions for drug products.
CDE

CDE

AI Workflow
Zh-CNFree
A public Chinese regulatory database for querying breakthrough therapy drug designations from the Center for Drug Evaluation.

生物批签发

生物批签发

生物批签发

AI Workflow
Zh-CNFree
A web database for searching official Chinese records on the batch release of biological products such as vaccines and blood-derived medicines.
NMPA

NMPA

AI Workflow
Zh-CNFree
The NMPA online service portal is China's official web gateway for pharmaceutical and medical-device administrative filings, licensing, and regulatory submissions.

国家药品编码

国家药品编码

国家药品编码

AI Workflow
Zh-CNFree
国家药品编码 is a Chinese regulatory reference service for looking up national drug identification codes maintained by the NMPA.

药物警戒*NMPA

药物警戒*NMPA

药物警戒*NMPA

AI Workflow
Zh-CNFree
A regulatory web portal from China's NMPA covering pharmacovigilance policy, adverse-drug-reaction reporting rules and drug-safety notices.

EMA在审药物

EMA在审药物

EMA在审药物

AI Workflow
ENFree
A monthly-updated reference page listing human medicines currently under evaluation by the European Medicines Agency, useful for regulatory and pharma research.

AdisInsight

AdisInsight

AdisInsight

AI Workflow
ENPaid
AdisInsight is a Springer database that tracks drug pipelines, clinical trials, deals, and patents for pharmaceutical research and competitive intelligence.

GBI Health

GBI Health

GBI Health

AI Workflow
Zh-CNFree · Paid
GBI Health is a healthcare intelligence platform offering drug, market, and clinical data resources for pharmaceutical research and decision-making.
GBD

GBD

AI Workflow
ENFree
GBD is a global health research resource offering epidemiology datasets and results for analyzing disease burden across populations and regions.
CPM

CPM

AI Workflow
Zh-CNFree
CPM is a Chinese pharmaceutical intelligence database that tracks new drug research and development activity across the domestic market.

PharmaCompass

PharmaCompass

PharmaCompass

AI Workflow
ENFree · Paid
PharmaCompass is a web-based pharmaceutical industry intelligence platform that helps users research companies, pipelines, and market developments.